The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 20, 2024

Filed:

May. 25, 2023
Applicant:

Akagera Medicines, Inc., Boxford, MA (US);

Inventors:

Daryl C. Drummond, Lincoln, MA (US);

Dmitri B. Kirpotin, San Francisco, CA (US);

Mark E. Hayes, Mill Valley, CA (US);

Alexander Koshkaryev, Norwood, MA (US);

Ross B. Fulton, Southborough, MA (US);

Assignee:

Akagera Medicines, Inc., Boxford, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 39/215 (2006.01); A61K 39/385 (2006.01); A61K 47/24 (2006.01); A61K 47/28 (2006.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
A61K 39/385 (2013.01); A61K 39/215 (2013.01); A61K 47/24 (2013.01); A61K 47/28 (2013.01); A61K 47/6929 (2017.08); A61K 47/6935 (2017.08);
Abstract

The present disclosure provides for improved compositions of ionizable lipid nanoparticles for the delivery of therapeutic nucleic acids to cells. Anionic phospholipids, including phosphatidylserine and phosphatidylglycerol are included in the lipid nanoparticles to increase the transfection efficiency in human dendritic cells. The further incorporation of mono-unsaturated alkyl chain analogs in dimethylaminopropyl-dioxolane or heterocyclic ketal ionizable lipids in the formulation demonstrated high levels of transfection in human dendritic cells, compared to other ionizable lipids in the same family, and demonstrated good stability to oxidative damage. Finally, the use of an ammonium salt of phosphatidylserine allows for the efficient production of PS-targeted LNPs.


Find Patent Forward Citations

Loading…